ArticleFrontiers in oncology2026
Ultra-rapid peritoneal dissemination of a somatic STK11-mutant adnexal tumor: a case report with molecular correlation and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STK11-adnexal tumor (STK11-AT) is a recently characterized rare neoplasm tightly linked to Peutz-Jeghers syndrome (PJS) and marked by high recurrence potential. We report a 38-year-old woman who presented with a pelvic mass 9 months after resection of a primary left fallopian tube tumor. Initial pathology suggested a malignant Wolffian duct tumor, but expert pathological review and molecular profiling confirmed STK11-AT harboring a somatic STK11 nonsense mutation (c.367C>T, p.Gln123*), identified via next-generation sequencing (NGS) with a variant allele frequency (VAF) of 88.55%. Despite postoperative normalization of serum CA-125, surveillance imaging revealed ultra-rapid recurrence with extensive peritoneal carcinomatosis and retroperitoneal lymph node metastasis, necessitating comprehensive cytoreductive surgery. Recurrent lesions exhibited a high Ki-67 proliferation index (70%), consistent with aggressive biological behavior. This case expands the clinicopathological spectrum of STK11-AT by documenting hyperacute progression (shorter than the reported median recurrence interval of 17 months) and highlights the critical role of definitive molecular testing for diagnosis, as well as the need for intensive long-term surveillance even after R0 resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.